Urinary Bladder – Talk Bio

Actionable Insights Powered by AI

Breakthroughs in Bladder Cancer Treatment: Protara and CG Oncology Report Encouraging Outcomes

5 months ago talkbio0Tagged Carcinoma of urinary bladder, invasive, Cell Therapy, centigram, Cretostimogene Grenadenorepvec, Lyophilized Inactivated Group A Streptococcus TARA-002, Malignant Neoplasms, Neoplasms, Non-Muscle, Non-Muscle Invasive Bladder Neoplasms, Oncolytic Immunotherapy, Protara Therapeutics, Urinary Bladder

Bladder Cancer Treatment, Protara Therapeutics, CG Oncology, TARA-002, Cretostimogene Grenadenorepvec, Non-Muscle Invasive Bladder Cancer (NMIBC), Oncolytic Immunotherapy, Cell Therapy

ImmunityBio Trims Workforce Despite Recent FDA Approval for Anktiva

8 months ago talkbio0Tagged Anktiva, Approved, Cancer Therapeutic Procedure, Financial Stress, ImmunityBio, United States Food and Drug Administration, Urinary Bladder

ImmunityBio, Anktiva, FDA approval, layoffs, financial challenges, bladder cancer treatment